IEQ Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

IEQ Capital’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,819	Closed	-$134K	–	2018
2026 Q1	$134K	Sell	10,819 -81,249	-88%	-$1.09M	﹤0.01%	1764
2025 Q4	$1.16M	Sell	92,068 -4,780	-5%	-$54.7K	﹤0.01%	980
2025 Q3	$969K	Buy	96,848 +23,859	+33%	+$214K	﹤0.01%	1008
2025 Q2	$590K	Buy	72,989 +38,662	+113%	+$291K	﹤0.01%	1090
2025 Q1	$288K	Buy	+34,327	New	+$287K	﹤0.01%	1204

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

IEQ Capital's AMRX Position: Q2 2026 in Review

IEQ Capital sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 10,819 shares — an estimated $134K sold.

IEQ Capital first reported a position in AMRX in Q1 2025 and held it in 5 quarters. The position peaked at $1.16M in Q4 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

IEQ Capital reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
IEQ Capital sold 10,819 Amneal Pharmaceuticals shares in Q2 2026, an estimated $134K.
IEQ Capital first reported a position in Amneal Pharmaceuticals in Q1 2025 and held it in 5 quarters.
IEQ Capital's Amneal Pharmaceuticals position peaked at $1.16M in Q4 2025.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.